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This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).SUMMARYMurine- and human-induced pluripotent stem cell-derived neural stem/progenitor cells (iPSC-NS/PCs) promote functional recovery
following transplantation into the injured spinal cord in rodents and primates. Although remyelination of spared demyelinated axons
is a criticalmechanism in the regeneration of the injured spinal cord, human iPSC-NS/PCspredominantly differentiate into neurons both
in vitro and in vivo. We therefore took advantage of our recently developed protocol to obtain human-induced pluripotent stem cell-
derived oligodendrocyte precursor cell-enriched neural stem/progenitor cells and report the benefits of transplanting these cells in a spi-
nal cord injury (SCI)model.We describe how this approach contributes to the robust remyelination of demyelinated axons and facilitates
functional recovery after SCI.INTRODUCTION
Previous studies describing functional recovery following
transplantation of neural stem/progenitor cells (NS/PCs)
in spinal cord injury (SCI) models demonstrated the thera-
peutic promise of this approach (Cummings et al., 2005;
Iwanami et al., 2005). A number of putative underlying
mechanisms have been suggested, including cell replace-
ment by grafted NS/PC-derived neurons, astrocytes, and ol-
igodendrocytes; trophic support for increased survival of
the host neural cells and host-mediated repair processes;
and, more recently, axonal remyelination by grafted NS/
PC-derived oligodendrocytes (Cummings et al., 2005;
Keirstead et al., 2005; Salewski et al., 2015; Yasuda et al.,
2011). Human NS/PCs and human-induced pluripotent
stem cell-derived NS/PCs (hiPSC-NS/PCs) predominantly
differentiate into neurons, and, to a lesser extent, into
mature oligodendrocytes both in vitro and in vivo (Kobaya-
shi et al., 2012; Nori et al., 2011, 2015; Romanyuk et al.,
2015).We therefore developed a protocol for the induction
of oligodendroglial differentiationof hiPSC-NS/PCs in vitro
(Numasawa-Kuroiwa et al., 2014). In the present study, we
used a pre-evaluated safe line of induced pluripotent stem
cells (iPSCs; 201B7) (Nori et al., 2011, 2015) and induced
their differentiation into oligodendrocyte precursor cell-
enriched NS/PCs (hiPSC-OPC-enriched NS/PCs). The aim
of this study was to evaluate the therapeutic potential of
hiPSC-OPC-enriched NS/PCs in the treatment of SCI.RESULTS
hiPSC-OPC-Enriched NS/PCs Differentiate into
Mature Oligodendrocytes In Vitro and In Vivo
We induced hiPSC-OPC-enriched NS/PCs from a pre-evalu-
ated safe iPSC line (201B7) (Nori et al., 2011) following a
previously reported protocol (Numasawa-Kuroiwa et al.,
2014) (Figure S1). Immunocytochemical analyses revealed
that hiPSC-OPC-enriched NS/PCs differentiated into
myelin basic protein (MBP)+ mature oligodendrocytes
in vitro. This differentiation was not observed using con-
ventional hiPSC-NS/PCs prepared following previously re-
ported protocols (Nori et al., 2011). hiPSC-OPC-enriched
NS/PCs also differentiated into b-tubulin isotype III
(bIII tubulin)+ neurons and glial fibrillary acidic protein
(GFAP)+ astrocytes (Figure 1A). Furthermore, the cytokine
expression profile list obtained using a cytokine antibody
array showed that significantly higher levels of vascular
endothelial growth factor (VEGF) and platelet-derived
growth factor (PDGF)-AAwere secreted into the cultureme-
dium of hiPSC-OPC-enriched NS/PCs than into that of
conventional hiPSC-NS/PCs (Figure 1B). Other cytokines
such as b-nerve growth factor, brain-derived neurotrophic
factor, ciliary neurotrophic factor, glial cell-derived neuro-
trophic factor, hepatocyte growth factor, neurotrophin-3,
and neurotrophin-4 were not detected in either group.
Contusive SCI was induced at the Th10 level in NOD-
SCID mice, and 5 3 105 hiPSC-OPC-enriched NS/PCsStem Cell Reports j Vol. 6 j 1–8 j January 12, 2016 j ª2016 The Authors 1
hiPS-OPC-
  enriched
  NS/PCs
hiPS-NS/PCs
MBP GFAP βⅢtubulin Merge
A
C
0 
10 
20 
30 
40 
50 
0 
10 
20 
30 
40 
50 
0 
10 
20 
30 
40 
50 
%
 o
f H
N
A
+  
 c
el
ls
APC
Nestin
Hu
GFAP
migrated cellscells at the lesion site total cells
APC GFAP Hu   Nestin
B
pg
/1
00
0 
ce
lls
hiPS-OPC-
  enriched
  NS/PCs
hiPS-NS/PCs
VEGF PDGF-AA
HNA
Hoechst Merge
HNA
Hoechst Merge
HNA
Hoechst Merge
HNA
Hoechst Merge
Migrated cells  Cells at the lesion siteD
E
0
2
4
6
8
10
12
14
0
0.2
0.4
0.6
0.8
1
STEM121 STEM121
pg
/1
00
0 
ce
lls
F
STEM121
Figure 1. Differentiation Potential of hiPSC-OPC-Enriched NS/PCs In Vitro and In Vivo
(A) Representative immunocytochemical images of three neural lineage cells (neurons, bIII tubulin: astrocytes, GFAP; oligodendrocytes,
MBP). Scale bar, 100 mm.
(B) Quantification of secreted cytokines from hiPSC-OPC-enriched NS/PCs and hiPSC-NS/PCs. Secretion of VEGF and PDGF-AA was
significantly higher in hiPSC-OPC-enriched NS/PC cultures than in hiPSC-NS/PC cultures (n = 3 independent experiments).
(C) STEM121+ grafted cells were integrated at the lesion epicenter (white arrows) and migrated rostrally and caudally (blue arrows). Scale
bar, 500 mm.
(D) Representative images of STEM121+ grafted cells at the lesion site and distant areas. Scale bar, 50 mm.
(E) Representative images of HNA+ grafted cells together with APC+ oligodendrocytes, GFAP+ astrocytes, Hu+ neurons, and Nestin+
immature cells. Scale bar, 20 mm.
(F) Percentages of cell-type-specific marker-positive cells among HNA+-grafted cells at the lesion site, at distant areas, and in total cells
(n = 5 independent experiments).
See also Figures S1 and S2.
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were transplanted into the lesion epicenter 9 days later.
Twelve weeks after transplantation, we performed immu-
nohistochemical analyses using antibodies specific to
human cytoplasm (STEM121) (Cummings et al., 2005), hu-
man nuclear antigen (HNA), and cell-type-specificmarkers.
Engrafted hiPSC-OPC-enriched NS/PCs differentiated into
adenomatous polyposis coli CC-1 (APC)+ mature oligoden-
drocytes, Hu+ neurons, and GFAP+ astrocytes (Figure 1D).
Some transplanted cells were present at the lesion site,
and the others migrated diffusely into the host spinal
cord (Figure 1C). We quantified the proportion of HNA+
cells immunopositive for cell-type-specific markers in
each site. Of themigrated cells, 39.2% ± 3.1% had differen-
tiated into APC+/HNA+ mature oligodendrocytes, 33.3% ±
2.0% into GFAP+/HNA+ astrocytes, 29.9% ± 6.4% into
Hu+/HNA+ neurons, and 6.34% ± 2.5% into Nestin+/
HNA+ cells. At the lesion site, 33.6% ± 4.1% of HNA+ cells
were APC+/HNA+ mature oligodendrocytes, 36.6% ± 2.1%
were GFAP+/HNA+ astrocytes, 25.3% ± 4.8% were Hu+/
HNA+ neurons, and 22.6% ± 2.5% were Nestin+/HNA+
cells. Of the total population of differentiated cells within
the host spinal cord, 34.5% ± 3.7% were APC+ cells,
36.1% ± 1.8% were GFAP+ cells, 26.1% ± 5.0% were Hu+
cells, and 20.4% ± 2.2% were Nestin+ cells (Figure 1E).
Grafted hiPSC-OPC-Derived Mature Oligodendrocytes
Contribute to Remyelination
A number of STEM121+/MBP+ double-positive areas, i.e.,
areas including human oligodendrocytes, were observed
in white matter of the injured spinal cord (Figures 2A–
2C), suggesting that many engrafted cells had differenti-
ated into mature oligodendrocytes, forming thick sheathes
andmigrating diffusely intowhitematter, but not into gray
matter, of the injured spinal cord (Figures 2D–2F). We
labeled transplanted cells with Venus fluorescent protein
engineered from the original GFP (Nagai et al., 2002).
Immunohistochemical analyses revealed large amounts
of GFP+/MBP+ double-labeled myelin sheaths surrounding
NF-H+ axons (Figure 2G), suggesting that graft-derived hu-
man oligodendrocytes form myelin sheaths. Immunoelec-
tron microscopy showed that immature myelin sheaths
were strongly associated with myelin cytoplasm with
nanogold-labeled GFP+ spots (Figure 2H). These results
indicate that transplanted hiPSC-OPC-derived oligoden-
drocytes form mature myelin sheaths on spared axons. In
addition, nodes of Ranvier, identified with antibodies to
the paranodal Caspr protein (Rios et al., 2000) and the jux-
taparanodal voltage-gated potassium channel protein
Kv1.2 (Wang et al., 1993), were observed in transplanted
cell-derived myelin sheaths (Figure 2I). Luxol Fast Blue
(LFB) staining showed significant differences between the
transplantation and control groups in LFB+ myelinated
areas at all sites examined (Figure 2J). Furthermore, immu-nohistochemistry revealed thatMBP+ areas in whitematter
were significantly larger in the transplantation group than
in the control group (Figure S3).
Transplanted hiPSC-OPC-Enriched NS/PCs Promote
Axonal Growth and Contribute to Synapse Formation
between Graft Cell-Derived Neurons and Host Mouse
Neurons
We examined the effects of transplanted cells on axonal
growth after SCI by immunohistochemical analyses using
antibodies for anti-NF-H (amarker of large-diameter neuro-
filaments) and anti-5-hydroxytryptamine (5-HT; a marker
of raphespinal serotonergic fibers). NF-H+ neuronal fibers
were prominent in the transplantation group compared
with the control group. There were statistically significant
differences in NF-H+ areas at all sites examined between
the two groups (Figure 3A). At the lumbar enlargement,
more 5-HT+ serotonergic fibers were observed in the trans-
plantation group than in the control group (Figure 3B).
To assess the ability of transplanted cell-derived neurons
to integrate with the host neural circuitry, we performed
triple immunostaining with antibodies to HNA, bIII
tubulin, and mouse-specific Bassoon (Bsn), a presynaptic
marker. bIII tubulin+/HNA+ graft-derived neurons co-local-
ized with Bsn+ synaptic boutons of host neurons (Fig-
ure 3C). Triple immunostaining for HNA, bIII tubulin,
and human-specific synaptophysin (hSyn) revealed that
hSyn+ synaptic boutons were apposed to bIII tubulin+/
HNA host mouse neurons (Figure 3C). These findings sug-
gest that graft-derived neurons integrate with host
neuronal circuits and form synapses.
Transplanted hiPSC-OPC-Enriched NS/PCs Enhance
Functional Recovery Following SCI
Recovery of motor function was assessed by the Basso
Mouse Scale (BMS), Rota-rod test, and DigiGait analysis.
The BMS score indicated significantly improved motor
function in the transplantation group compared with the
control group at 35 days post-SCI and beyond (Figure 4A).
In the Rota-rod treadmill test, transplanted mice were able
to run for significantly longer than controlmice at 12weeks
after transplantation (Figure 4B). Using the DigiGait Image
Analysis System to analyze gait, we found that stride was
significantly longer in the transplantation group than in
the control group at 12 weeks after transplantation
(Figure 4C).
Because remyelination facilitates the restoration of rapid
nerve conduction, we performed electrophysiological ex-
amination using the motor-evoked potential (MEP) at
12 weeks post-transplantation. The latency of the MEP in
eachwavewasmeasured starting from the time of the stim-
ulus. Although we detected an MEP wave in all trans-
planted mice, we detected MEP waves in only 50% ofStem Cell Reports j Vol. 6 j 1–8 j January 12, 2016 j ª2016 The Authors 3
Figure 2. Grafted hiPSC-OPC-Derived Oli-
godendrocytes Contribute to Remyelina-
tion of Spared Axons
(A–C) Representative images of sagittal
sections stained for STEM121 and MBP.
STEM121+/MBP+ hiPSC-OPC-derived mature
oligodendrocytes migrated rostrally and
caudally. Scale bar, 500 mm in (A), 300 mm
in (B) and (C).
(D–F) Representative images of stained
axial sections. hiPSC-OPC-derived oligo-
dendrocytes migrated into white matter
broadly. The region enclosed by the dashed
line indicates the dorsal root. Scale bar,
300 mm in (D), 100 mm in (E), and 20 mm
in (F).
(G) Representative images of axial sections
stained for MBP, GFP, and NF-H. Many GFP+/
MBP+ double-labeled myelin sheaths were
observed around NF-H+ neuronal fibers.
Scale bar, 10 mm.
(H) Representative images of immunoelec-
tron microscopy. Grafted cells were detect-
able by the black dots observed upon anti-
GFP antibody staining. Anti-GFP antibody
labeling was often observed in the outer
cytoplasm of the myelin sheath (blue
arrows). At a high magnification, remyeli-
nated axons surrounded by GFP+ trans-
planted cells were identified. Scale bar,
2 mm (left), 200 nm (right).
(I) Representative images of sagittal sec-
tions stained for GFP, Caspr, and Kv1.2.
Nodes of Ranvier, identified with antibodies
for the paranodal Caspr protein and the
juxtaparanodal voltage-gated potassium
channel protein Kv1.2, were observed in
GFP+ myelin sheathes. Scale bar, 10 mm.
(J) Representative images of LFB staining at
the lesion epicenter and at sites 1-mm rostral and caudal. Scale bar, 200 mm. Quantitative analyses revealed a significantly larger
myelinated area in the transplantation group than in the control group. Values are means ± SEM (control group, n = 6; transplantation
group, n = 5; *p < 0.05).
See also Figure S3.control mice (Figure 4D). MEP latency was significantly
longer in the control group than in the transplantation
group (Figure 4D), suggesting that graft-derived oligoden-
drocytes contribute to an increase in myelinated fibers.DISCUSSION
Transplanted hiPSC-OPC-Derived Oligodendrocytes
Contribute to Remyelination of Spared Axons
The 201B7 hiPSC line is considered to be a safe clone based
on previous studies showing the absence of observed4 Stem Cell Reports j Vol. 6 j 1–8 j January 12, 2016 j ª2016 The Authorstumorigenic propensities upon transplantation into the
SCImodel of NOD/SCIDmice (Nori et al., 2015). In the pre-
sent study, we used these safe iPSCs and prepared hiPSC-
derived OPC-enriched NS/PCs as a cell source to treat SCI
in adult NOD-SCID mice. Tumor formation was not
observed at 12 weeks after transplantation.
Transplantation of hiPSC-OPC-enriched NS/PCs pro-
moted functional recovery after SCI via differentiation
into neurons, astrocytes, and mature oligodendrocytes.
Using conventional hiPSC-NS/PCs, approximately 50% of
grafted cells differentiate into neurons and only 3% differ-
entiate into APC+ oligodendrocytes (Nori et al., 2011),
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Figure 3. Transplanted hiPSC-OPC-Enriched NS/PCs Promote
Axonal Growth and Contribute to Synapse Formation between
Grafted Cell-Derived Neurons and Host Mouse Neurons
(A) Representative images of NF-H+ neurofilament staining. Scale
bar, 200 mm (upper) and 20 mm (lower). Quantification of NF-H+
areas revealed that neuronal fiber areas were significantly larger in
the transplantation group than in the control group. Values are
means ± SEM (n = 5, **p <0.01).
(B) Representative images of axial sections stained for 5-HT at
4-mm caudal to the epicenter. Black arrows indicate 5-HT+ fibers.
Scale bar, 50 mm. Quantitative analyses revealed that there were
significantly more 5-HT+ fibers in the transplantation group than in
the control group. Values are means ± SEM (control group, n = 6;
transplantation group, n = 5; *p < 0.05).
(C) Representative images showing staining for HNA, bIII tubulin,
and the human-specific presynaptic marker hSyn or the mouse
presynaptic marker Bsn. hSyn+ boutons were apposed to bIII
tubulin+/HNA host mouse neurons (left). In addition, bIII
tubulin+/HNA+ grafted cell-derived neurons were observed in con-
tact with Bsn+ cells. Scale bar, 10 mm.
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Figure 4. Transplantation of hiPSC-OPC-enriched NS/PCs
Promotes Motor Functional and Electrophysiological Recovery
after SCI
(A) The BMS score showed that functional recovery was signifi-
cantly better in the transplantation group than in the control group
at 35 days after SCI and thereafter. Values are means ± SEM (control
group, n = 8; transplantation group, n = 5; *p < 0.05).
(B) Time on the rotating rod in each group at 12 weeks after
transplantation. Transplanted mice could run on the rod for
significantly longer than control mice. Values are means ± SEM
(control group, n = 8; transplantation group, n = 5; **p < 0.01).
(C) Treadmill gait analyses using the DigiGait System at 12 weeks
after transplantation. Stride length was significantly longer in
the transplantation group than in the control group. Values are
means ± SEM (control group, n = 8; transplantation group, n = 5;
**p < 0.01).
(D) Electrophysiological analyses at 12 weeks after transplantation.
Although MEP waves were detected in all transplanted mice, no
waves were detected in 50% of control mice. The graph shows the
latency of the MEP in transplanted mice and control mice in which
waves were observed. The latency was significantly shorter in
the transplantation group than in the control group. Values are
means ± SEM (control group, n = 5; transplantation group, n = 5;
*p < 0.05).while 35% of hiPSC-OPC-enriched NS/PCs differentiate
into mature oligodendrocytes. Moreover, immunohisto-
chemistry and electronmicroscopy revealed direct remyeli-
nation of spared axons.
Post-SCI inflammation has both beneficial and delete-
rious effects on transplanted cells. Inflammation may pro-
mote the survival and migration of transplanted cells by
inducing the secretion of trophic factors (CopelmanStem Cell Reports j Vol. 6 j 1–8 j January 12, 2016 j ª2016 The Authors 5
et al., 2000; Diemel et al., 2003; Hinks and Franklin, 1999);
however, phagocytosis and the release of pro-inflamma-
tory cytokines by activated macrophages and microglia
can harm engrafted cells (Bartnik et al., 2000). One feature
ofOPCs is their ability tomigrate into demyelinated lesions
(Piaton et al., 2011). Previous studies using rat models of
multiple sclerosis showed that OPCs migrate toward in-
flamed demyelinated lesions (Wang et al., 2011), suggest-
ing that inflammation affects migration and interactions
between OPCs and host tissue. Consistent with this, we
found that transplanted hiPSC-OPCs migrate broadly
into host white matter and contribute extensively to re-
myelination of demyelinated axons. Such effects may
contribute to the improvement of locomotor function.
Graft Cell-Derived Neurons Contribute to Neuronal
Relay by Synapse Formationwith HostMouse Neurons
Previous studies demonstrated post-SCI functional
improvement associated with grafted neuronal progenitor
cells (Abematsu et al., 2010; Bonner et al., 2010; Cummings
et al., 2005). Abematsu et al. (2010) reported that ablation
of transplanted iPSC-NS/PCs leads to loss of motor func-
tion, suggesting that the survival of graft-derived cells is
essential to maintain function. They also showed that
graft-derived human neurons receive projections from
host mouse neurons, and that their extended processes
form synapses with host neurons. In this study, grafted
hiPSC-OPC-enriched NS/PCs differentiated into both oli-
godendrocytes and neurons capable of forming synapses
with host neurons within the injured spinal cord, suggest-
ing that the reconstruction of neuronal circuits also plays a
substantial role in functional recovery after transplanta-
tion of hiPSC-OPC-enriched NS/PCs. All et al. (2015)
reported the effectiveness of hiPSC-derived OPC transplan-
tation for SCI in rats. However, their cells predominantly
differentiate into oligodendrocytes, and less so into
neurons. Graft-derived neurons are also expected to play
a significant role in improving functional recovery after
transplantation.
We did not transplant conventional hiPSC-NS/PCs
in this study becausewe reported solid data about the trans-
plantation of conventional hiPSC-NS/PCs into an SCI
model in NOD/SCIDmice (prepared under the same condi-
tions as in the present study) in our previous studies (Nori
et al., 2011, 2015). Thus, we simply compared the behav-
ioral data of two groups (animals grafted with hiPSC-
OPC-enriched NS/PCs in the present study and those
grafted with conventional hiPSC-NS/PCs in previous
studies). Although the therapeutic potential of hiPSC-
OPC-enriched NS/PCs should in theory differ from that
of conventional hiPSC-NS/PCs, we did not find any differ-
ences in the BMS score, the Rota-rod treadmill test, or the
DigiGait Image Analysis System, which may reflect diffi-6 Stem Cell Reports j Vol. 6 j 1–8 j January 12, 2016 j ª2016 The Authorsculties in assessing motor function in mice and in differen-
tiating between the two groups. Further studies using larger
animal SCI models, such as common marmosets, which
will enable us to evaluate skilled movements, may be
needed to obtain significant differences in motor function
recovery between hiPSC-OPC-enriched NS/PC and hiPSC-
NS/PC transplantation.Grafted Cell-Derived Trophic Factors Enhance the
Survival of Host Neural Cells and Host-Mediated
Regeneration and Repair without Tumorigenicity
Axonal regrowth supported by astrocytes derived from
transplanted cells may be another reason for the observed
recovery. A previous report indicated that graft cell-derived
immature astrocytes in injured spinal cords promote the
outgrowth of 5-HT+ fibers by providing a growth-permis-
sive surface (Hofstetter et al., 2002). Consistent with this,
transplantation of hiPSC-OPC-enriched NS/PCs promoted
serotonergic innervation of the distal cord compared with
vehicle control mice, and the release of trophic factors by
undifferentiated NS/PCs may protect against neural cell
death, and, hence, glial scar formation (Brock et al., 2010;
Tuszynski et al., 1996). Here, we show that hiPSC-OPC-
enriched NS/PCs secrete several growth factors in vitro,
enhance the sparing and/or regrowth of NF-H+ neuronal
fibers, and prevent atrophy of the injured spinal cord.
In conclusion, OPC-enriched NS/PCs derived from the
human iPSC clone 201B7 survived and differentiated into
three neural lineage cells in the injured spinal cord of adult
mice, with no evidence of tumor formation. Oligodendro-
cytes derived from transplanted cells may thus play a key
role in promoting functional recovery by remyelinating
spared axons.EXPERIMENTAL PROCEDURES
Cell Culture, Neural Induction, and Lentivirus
Transduction
Culture and neural induction of hiPSCs (201B7) were performed as
described previously (Numasawa-Kuroiwa et al., 2014). Lentivirus
was prepared and transduced into neurospheres according to pre-
viously described methods (Okada et al., 2008). Briefly, hiPSC-
derived primary neurospheres were dissociated and infected with
lentivirus-expressing Venus fluorescent protein under the control
of the elongation factor promoter (pCSII-EF-Venus). These primary
neurospheres were passaged into secondary neurospheres and
used for transplantation.SCI Model and Transplantation
Contusive SCI was induced at the Th10 level in spinal cords of
adult female NOD-SCID mice. Nine days after injury, 5 3 105
hiPSC-OPC-enriched NS/PCs were transplanted into the lesion
epicenter of each mouse. All experiments were approved by the
ethics committee of Keio University. Detailed methods are
described in the Supplemental Information.Motor Function Analyses
Hindlimb motor function was evaluated for 12 weeks after
transplantation using the BMS (Basso et al., 2006), a rotating rod
apparatus, and the DigiGait System (Mouse Specifics). Detailed
methods are described in the Supplemental Information.Histological Analyses
Histological analyses were performed at 12weeks after transplanta-
tion. Sections were evaluated by H&E staining, LFB staining, and
immunohistochemistry. Detailed protocols are described in the
Supplemental Information.Statistical Analyses
All data are reported as the mean ± SEM. For all histological exam-
inations, an unpaired two-tailed Student’s t-test was used for single
comparisons between the transplantation and vehicle control
groups. The BMS scores were analyzed using the Mann-Whitney
U-test. In each case, *p < 0.05 and **p < 0.01 were considered to
be statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and three figures and can be found with this article
online at http://dx.doi.org/10.1016/j.stemcr.2015.11.013.
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